MPs say the NHS rollout of weight-loss drug Mounjaro is too limited, with early plans indicating only around 6% of eligible people will receive the injections. Several outlets report that this access figure is linked to a three-year programme starting in 2024.
BBC, the Evening Standard, and right-leaning papers all frame the issue around calls from MPs to expand eligibility and increase the number of people who can access the treatment. The debate centers on whether current targets are ambitious enough and highlights concerns that demand is not being met by the pace of implementation.
While the outlets largely agree on the headline figure—about 6% of eligible patients—their emphasis differs slightly. The Evening Standard foregrounds criticism of the rollout as “unambitious” by MPs. The BBC similarly points to MPs’ calls to “give more” weight-loss jabs on the NHS. The Daily Mail and Mail Online stress that the figure leaves millions without access and describe the report as cross-party, while still centering the same 6% figure and the timeline of the rollout.
